Home » Topics » BioWorld Science

BioWorld Science
RSS

Omeros divulges new MASP2 inhibitors

July 5, 2021

Genzyme patents new CFTR modulators

July 5, 2021

Sanofi initiates early clinical studies of SAR-444245

July 5, 2021

Arrowhead voluntarily pauses phase I/II study of ARO-ENaC in CF

July 5, 2021

Washington University reports dosimetry data for brain PET radiotracer [11C]CS1P1

July 5, 2021

ALICE study data support iadademstat with azacitidine in acute myeloid leukemia

July 5, 2021

Results of phase I dose-escalation study of MVC-COV-1901 SARSCoV-2 vaccine candidate

July 5, 2021

Identification of a vitamin D3 analogue inducing SREBP degradation without calcemic action

July 5, 2021

Neoantigen-specific cytotoxic T cells show in vivo efficacy in Ewing sarcoma

July 2, 2021

Phase II trial evaluates bepranemab in mild cognitive impairment or mild Alzheimer's disease

July 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...